Objectives: The most effective treatment step in morbid obesity is surgical treatment. The purpose of the present study was to investigate the long-term follow-up results and success rates in patients who were applied laparoscopic adjustable gastric band.
Material And Methods: The change in body mass index, percentage of excess weight loss, comorbidities, and resulting complications were investigated in 220 patients who were morbidly obese who were applied laparoscopic adjustable gastric band between April 2006 and February 2012 throughout the 6-year follow-up period. Forty-six patients who did not show up for their routine follow-ups were excluded from the study.
Results: In the present study, the band removal percentage was 35.63%. The percentage of excess weight loss in patients who were followed up without removal of the band was 46.03%. Complications were observed in 46.5% of the patients. The most frequently observed complication among the major complications was band intolerance, which is also the most common cause of band removal. Band removal was considered as a failure in laparoscopic adjustable gastric band operations, and patients were referred to other surgical methods.
Conclusion: When improved patient compliance and careful and close patient follow-up are provided in the early stages of laparoscopic adjustable gastric band application, it may be possible to reach percentage of excess weight loss results that would be the nearest to those achieved by gastric bypass or sleeve gastrectomy methods. However, high complication rates and necessity to perform other bariatric surgical procedures in the majority of the patients in the long-term follow-up suggest that the laparoscopic adjustable gastric band operation is not the first choice in bariatric surgery.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.5152/turkjsurg.2018.4038 | DOI Listing |
Curr Urol Rep
November 2024
Department of Urology, Indiana University, 11725 North Illinois Street - Carmel, Indianapolis, IN, IN - 46032, United States of America.
Cureus
October 2024
Surgery Department, Hospital Zambrano Hellion TecSalud, San Pedro Garza García, MEX.
Obesity has been recognized as the main pandemic of this century. Multiple treatments have been developed: the use of medications, exercise, diet, and surgery. Bariatric surgery is one of the treatments that has shown the greatest effectiveness.
View Article and Find Full Text PDFSurg Obes Relat Dis
January 2025
Minimally Invasive Bariatric & General Surgery, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio. Electronic address:
Background: Metabolic and bariatric surgery is a safe and effective treatment strategy for severe childhood obesity, affecting 10% of US adolescents.
Objectives: This prospective observational study addresses knowledge gaps related to changes in weight, cardiometabolic risk, and weight-related quality of life (WRQOL) in adolescents 10 years after laparoscopic adjustable gastric band (LAGB) insertion.
Setting: Five Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) US centers.
Int J Obes (Lond)
November 2024
Department of Endocrinology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Background: Endoscopic bariatric surgery (EBS) is a new treatment for obesity. We compared the efficacy, safety, and probability of metabolic complications of different EBSs with laparoscopic sleeve gastrectomy (LSG).
Methods: This systematic review and network meta-analysis (NMA) included searches of PubMed, Web of Science, and the Cochrane Library from January 1, 2017, to December 27, 2022, to find comparative trials of EBS procedures and EBS with LSG.
Med J Aust
December 2024
The Australian Centre for Accelerating Diabetes Innovations, Melbourne Medical School, the University of Melbourne, Melbourne, VIC.
Objectives: To review studies of interventions for reducing the impact of type 2 diabetes in Aboriginal and Torres Strait Islander people. The primary aim was to review and summarise the characteristics and findings of the interventions. The secondary aims were to assess their effects on diabetes and cardiometabolic risk factors, and the proportions of people with type 2 diabetes who achieved therapeutic targets with each intervention.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!